Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
|
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma
    She, Wong Hoi
    Cheung, Tan To
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (18) : 2479 - 2481
  • [2] Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
    Tomonari, Tetsu
    Tani, Joji
    Sato, Yasushi
    Tanaka, Hironori
    Tanaka, Takahiro
    Taniguchi, Tatsuya
    Kawano, Yutaka
    Morishita, Asahiro
    Okamoto, Koichi
    Sogabe, Masahiro
    Miyamoto, Hiroshi
    Masaki, Tsutomu
    Takayama, Tetsuji
    CANCERS, 2023, 15 (21)
  • [3] Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects
    Ma, Ya-nan
    Jiang, Xuemei
    Liu, Hui
    Song, Peipei
    Tang, Wei
    BIOSCIENCE TRENDS, 2023, 17 (06) : 415 - 426
  • [4] Conversion therapies for initially unresectable hepatocellular Carcinoma
    Fritsch, J.
    Ardelt, M.
    Settmacher, U.
    CHIRURGIE, 2025, 96 (01): : 65 - 66
  • [5] Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
    Farasati Far, Bahareh
    Rabie, Dorsa
    Hemati, Parisa
    Fooladpanjeh, Parastoo
    Faal Hamedanchi, Neda
    Broomand Lomer, Nima
    Karimi Rouzbahani, Arian
    Naimi-Jamal, Mohammad Reza
    LIVERS, 2023, 3 (01): : 121 - 160
  • [6] The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy
    Yoshimoto, Toshiaki
    Imura, Satoru
    Morine, Yuji
    Ikemoto, Tetsuya
    Arakawa, Yusuke
    Iwahashi, Shuichi
    Saito, Yu
    Takasu, Chie
    Ishikawa, Daichi
    Teraoku, Hiroki
    Bando, Yoshimi
    Shimada, Mitsuo
    ANTICANCER RESEARCH, 2018, 38 (01) : 501 - 507
  • [7] Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib Three case reports
    Tomonari, Tetsu
    Sato, Yasushi
    Tanaka, Hironori
    Tanaka, Takahiro
    Taniguchi, Tatsuya
    Sogabe, Masahiro
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Saito, Yu
    Imura, Satoru
    Bando, Yoshimi
    Shimada, Mitsuo
    Takayama, Tetsuji
    MEDICINE, 2020, 99 (42) : E22782
  • [9] Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
    Chen, Kang
    Luo, Cheng-Piao
    Ge, De-Xiang
    Wang, Ke-Lin
    Luo, Qin
    Li, Yan-Zhi
    You, Xue-Mei
    Xiang, Bang-De
    Li, Le-Qun
    Ma, Liang
    Zhong, Jian-Hong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
    Deng, Gan-Lu
    Zeng, Shan
    Shen, Hong
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (05) : 787 - 798